IAA21 is a member of the Aux/IAA family of proteins involved in auxin signaling in plants. These proteins function as transcriptional regulators that mediate auxin responses through interaction with auxin response factors (ARFs). The IAA21 antibody specifically recognizes the IAA21 protein (Q5Z749 in Oryza sativa subsp. japonica), allowing researchers to study its expression, localization, and function in plant development .
Based on available antibody specifications, IAA21 antibodies have been primarily characterized for use in rice (Oryza sativa) research . While the antibody targets rice IAA21 protein, researchers should validate cross-reactivity when applying it to other plant species. The antibody has been most extensively validated in Oryza sativa subsp. japonica model systems .
The IAA21 antibody is designed to specifically recognize epitopes unique to the IAA21 protein, distinguishing it from other IAA family members (like IAA4, IAA5, IAA7, IAA8, IAA12, IAA13, etc.) that are also studied in plant research . Each IAA protein has distinct functions in auxin signaling pathways, necessitating specific antibodies for precise detection and analysis.
Several techniques are appropriate for IAA21 detection:
Western blotting: Primary method for determining IAA21 protein abundance
Immunohistochemistry/Immunofluorescence: For examining tissue-specific localization
Immunoprecipitation: For studying protein-protein interactions
ELISA: For quantitative measurement of IAA21 levels
Researchers should consider optimization of extraction buffers to effectively solubilize membrane-associated IAA proteins while preserving their native conformations for antibody recognition.
A comprehensive control strategy should include:
Positive control: Tissue known to express IAA21 (e.g., specific rice tissue types)
Negative control: Tissue where IAA21 is absent or from IAA21 knockout/knockdown plants
Secondary antibody-only control: To assess non-specific binding
Pre-absorption control: IAA21 antibody pre-incubated with purified antigen
Cross-reactivity assessment: Testing against other IAA family proteins
These controls help validate antibody specificity and experimental reliability.
Optimization considerations include:
Tissue fixation: Different tissues may require modified fixation protocols to preserve IAA21 epitopes
Extraction buffers: Optimization based on subcellular localization of IAA21
Blocking reagents: BSA vs. non-fat milk testing to reduce background
Antibody concentration: Titration to determine optimal signal-to-noise ratio
Incubation conditions: Temperature and duration adjustments for different techniques
IAA21 antibody enables several advanced research approaches:
Quantification of IAA21 degradation kinetics following auxin treatment
Co-immunoprecipitation to identify IAA21 interacting partners
ChIP assays to study IAA21 association with chromatin when relevant
Protein dynamics studies during developmental transitions or stress responses
Comparative analysis of IAA21 with other Aux/IAA proteins to understand functional redundancy or specificity
Researchers face several challenges:
Protein instability: IAA proteins are often rapidly degraded following auxin signaling
Low endogenous expression: May require sensitive detection methods
Post-translational modifications: Can affect antibody recognition
Functional redundancy: Necessitates careful experimental design to distinguish specific IAA21 functions
Tissue-specific expression patterns: Requires optimization for different tissue types
Integrative approaches may include:
Immunoblotting in IAA21 mutant/overexpression lines to confirm altered protein levels
Protein localization studies in plants with modified auxin signaling components
Quantitative analysis of IAA21 protein levels in response to genetic perturbations
Correlation of protein data with transcriptomic/phenotypic analyses
Optimal storage recommendations:
Long-term storage: At -20°C in small aliquots to avoid freeze-thaw cycles
Working dilutions: At 4°C for up to two weeks
Stabilizers: Addition of carrier proteins (BSA) may enhance stability
Cryoprotectants: Glycerol (typically 50%) prevents freezing damage
Microbial contamination prevention: Addition of sodium azide (0.02-0.05%)
To improve specificity:
Optimize blocking: Test different blocking agents (5% BSA, non-fat milk)
Pre-adsorption: Consider pre-adsorbing antibody against tissues lacking IAA21
Washing optimization: Increase wash stringency with higher salt concentrations
Antibody dilution: Test serial dilutions to find optimal concentration
Cross-reactivity testing: Validate against recombinant IAA proteins if available
When facing inconsistent results:
Multiple detection methods: Confirm findings using independent techniques
Alternative antibody clones: If available, use antibodies recognizing different epitopes
Mass spectrometry validation: For definitive protein identification
RNA-protein correlation: Compare protein results with transcript levels
Genetic validation: Use IAA21 mutants to confirm antibody specificity
It's important to distinguish between these entirely different research areas:
| Characteristic | Plant IAA21 Antibody | Insulin AutoAntibody (IAA) |
|---|---|---|
| Target | IAA21 protein in plants | Insulin in mammals |
| Research field | Plant molecular biology | Type 1 diabetes research |
| Species | Plants (e.g., rice) | Humans and animal models |
| Function | Research tool for detecting plant proteins | Biomarker for autoimmune diabetes |
| Production | Laboratory-generated for research | Endogenously produced in autoimmune conditions |
The similar abbreviations can cause confusion, but these represent fundamentally different biological entities .
Methodological differences include:
Detection techniques: Plant IAA21 typically uses Western blotting and immunohistochemistry, while IAA in diabetes uses radioimmunoassay or ELISA
Sample preparation: Plant research uses tissue extraction, while diabetes research uses serum samples
Interpretation: Plant research focuses on protein abundance/localization, whereas diabetes research interprets IAA as a diagnostic/predictive biomarker
Cutoff values: Medical IAA testing uses established clinical thresholds, while plant IAA21 research uses relative quantification
Advanced approaches include:
Single-cell proteomics for cell-specific IAA21 analysis
Live-cell imaging with fluorescently tagged antibodies
Proximity labeling techniques to identify novel interacting partners
Cryo-electron microscopy for structural studies of IAA21-containing complexes
Antibody engineering for improved sensitivity and specificity
IAA21 research can provide insights into:
Cross-talk between auxin and other hormone signaling pathways
Evolutionary conservation of auxin signaling components across plant species
Stress adaptation mechanisms involving auxin-regulated gene expression
Developmental plasticity mediated by dynamic IAA protein function
Agricultural applications through manipulation of auxin response pathways